647 related articles for article (PubMed ID: 15701861)
1. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
2. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
Chen B; Pogue BW; Hoopes PJ; Hasan T
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
[TBL] [Abstract][Full Text] [Related]
3. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.
Chen B; Crane C; He C; Gondek D; Agharkar P; Savellano MD; Hoopes PJ; Pogue BW
Int J Cancer; 2008 Aug; 123(3):695-701. PubMed ID: 18498134
[TBL] [Abstract][Full Text] [Related]
4. Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.
Chen B; Pogue BW; Luna JM; Hardman RL; Hoopes PJ; Hasan T
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):917-23. PubMed ID: 16467106
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.
Momma T; Hamblin MR; Wu HC; Hasan T
Cancer Res; 1998 Dec; 58(23):5425-31. PubMed ID: 9850075
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment photosensitizer dosimetry reduces variation in tumor response.
Zhou X; Pogue BW; Chen B; Demidenko E; Joshi R; Hoopes J; Hasan T
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1211-20. PubMed ID: 16504761
[TBL] [Abstract][Full Text] [Related]
7. Analysis of effective molecular diffusion rates for verteporfin in subcutaneous versus orthotopic Dunning prostate tumors.
Zhou X; Pogue BW; Chen B; Hasan T
Photochem Photobiol; 2004 Apr; 79(4):323-31. PubMed ID: 15137508
[TBL] [Abstract][Full Text] [Related]
8. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy.
He C; Agharkar P; Chen B
Pharm Res; 2008 Aug; 25(8):1873-80. PubMed ID: 18446275
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density.
Wang Y; Gonzalez M; Cheng C; Haouala A; Krueger T; Peters S; Decosterd LA; van den Bergh H; Perentes JY; Ris HB; Letovanec I; Debefve E
Lasers Surg Med; 2012 Apr; 44(4):318-24. PubMed ID: 22362489
[TBL] [Abstract][Full Text] [Related]
10. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
11. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
Fateye B; Wan A; Yang X; Myers K; Chen B
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
Zacks DN; Ezra E; Terada Y; Michaud N; Connolly E; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
[TBL] [Abstract][Full Text] [Related]
13. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
[TBL] [Abstract][Full Text] [Related]
16. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
17. Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor.
Chen B; Pogue BW; Goodwin IA; O'Hara JA; Wilmot CM; Hutchins JE; Hoopes PJ; Hasan T
Radiat Res; 2003 Oct; 160(4):452-9. PubMed ID: 12968929
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts.
Koudinova NV; Pinthus JH; Brandis A; Brenner O; Bendel P; Ramon J; Eshhar Z; Scherz A; Salomon Y
Int J Cancer; 2003 May; 104(6):782-9. PubMed ID: 12640688
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes.
Lui H; Hobbs L; Tope WD; Lee PK; Elmets C; Provost N; Chan A; Neyndorff H; Su XY; Jain H; Hamzavi I; McLean D; Bissonnette R
Arch Dermatol; 2004 Jan; 140(1):26-32. PubMed ID: 14732656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
